Tempus Labs Inc (Tempus) is a healthcare technology company that collects and analyzes molecular, clinical and genomic data through the utilization of artificial intelligence technology. It collects clinical and genomic databases from academic medical centers and community-based hospitals. The company’s major services include genomic sequencing, clinical data structuring, image recognition, biological modeling and TIME Trial technology platform. It also offers clinical decision support services, analytical tools to access, analyze and interpret clinical and molecular data, and data solutions services for researchers. The company has collaborations with various institutes and hospitals and serves providers, payers, researchers, and life sciences companies. Tempus is headquartered in Chicago, Illinois, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Tempus Labs Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Tempus Labs Inc Company Overview
- Tempus Labs Inc Company Snapshot
- Tempus Labs Inc Pipeline Products and Ongoing Clinical Trials Overview
- Tempus Labs Inc - Pipeline Analysis Overview
- Tempus Labs Inc - Key Facts
- Tempus Labs Inc - Major Products and Services
- Tempus Labs Inc Pipeline Products by Development Stage
- Tempus Labs Inc Pipeline Products Overview
- Companion Diagnostic Test - Merkel Cell Carcinoma (MCC)
- Companion Diagnostic Test - Merkel Cell Carcinoma (MCC) Product Overview
- HLA-LOH Companion Diagnostic Test
- HLA-LOH Companion Diagnostic Test Product Overview
- SalivaDirect - COVID-19/Influenza
- SalivaDirect - COVID-19/Influenza Product Overview
- Tempus Labs Inc - Key Competitors
- Tempus Labs Inc - Key Employees
- Tempus Labs Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Tempus Labs Inc, Recent Developments
- Mar 14, 2024: Tempus Contributes De-Identified Cancer Data to Planned Data Enclave
- Feb 21, 2024: Tempus Expanding Access to its Next-Generation Sequencing Tests as an In-Network Provider for Cigna
- Jan 24, 2024: Tempus Is Now an In-Network Provider for Humana, Expanding Access to Its Next-Generation Sequencing Tests
- Jan 18, 2024: Tempus launches MRD assay for colorectal cancer research
- May 23, 2023: Tempus Labs receives CLIA approval for xT CDx Test
- May 11, 2023: Tempus Labs obtains Pre-Market Approval (PMA) for xT CDx Test
- Jan 05, 2023: Tempus announces prospective study for biomarker discovery in small cell lung cancer
- Oct 27, 2022: Tempus announces Real-World Data-driven program to accelerate precision oncology research
- Jun 06, 2022: Tempus Announces 14 Abstracts Accepted For Presentation at the American Society of Clinical Oncology Annual Meeting 2022
- Jun 03, 2022: Tempus to launch largest clinically available liquid biopsy panel, xF+
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Tempus Labs Inc Pipeline Products and Ongoing Clinical Trials Overview
- Tempus Labs Inc Pipeline Products by Equipment Type
- Tempus Labs Inc Pipeline Products by Indication
- Tempus Labs Inc, Key Facts
- Tempus Labs Inc, Major Products and Services
- Tempus Labs Inc Number of Pipeline Products by Development Stage
- Tempus Labs Inc Pipeline Products Summary by Development Stage
- Companion Diagnostic Test - Merkel Cell Carcinoma (MCC) - Product Status
- Companion Diagnostic Test - Merkel Cell Carcinoma (MCC) - Product Description
- HLA-LOH Companion Diagnostic Test - Product Status
- HLA-LOH Companion Diagnostic Test - Product Description
- SalivaDirect - COVID-19/Influenza - Product Status
- SalivaDirect - COVID-19/Influenza - Product Description
- Tempus Labs Inc, Key Employees
- Tempus Labs Inc, Subsidiaries
- Glossary
- Tempus Labs Inc Pipeline Products by Equipment Type
- Tempus Labs Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- InsightRX Inc
- Veritas Genetics Inc
- 23andMe Inc
- InsightRX Inc
- Veritas Genetics Inc
- 23andMe Inc
- Ancestry.com Holdings LLC
- Owkin Inc
- Owkin Inc
- Ancestry.com Holdings LLC
